Back to search

Article

Guidelines on the Diagnosis, Clinical Assessments, Treatment and Management for CLN2 Disease Patients

2020-10-28

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>: CLN2 disease (Neuronal Ceroid Lipofuscinosis Type 2), or Late-Infantile Neuronal Ceroid Lipofuscinosis (LINCL), is an ultra-rare, neurodegenerative lysosomal storage disease, caused by an enzyme deficiency of tripeptidyl peptidase 1 (TPP1). Lack of disease awareness and the non-specificity of presenting symptoms often leads to delayed diagnosis. These guidelines...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c14d19f7-bc98-50f1-be25-89bc9519c805
DOI
10.21203/rs.3.rs-96773/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Guidelines on the Diagnosis, Clinical Assessments, Treatment and Management for CLN2 Disease PatientsDOI 10.21203/rs.3.rs-96773/v1
Select a neighboring publication to make it the new centre.